Overactive Bladder Clinical Trials

If not, please take a few moments to fill out the form below. It’s free, and ensures that you receive regular alerts to the latest clinical news and other content.

Email*

Password*

Keep me logged in Forgot your password?

Email*

Painless Laser Therapy for Overactive Bladder (PLTOAB)

A Study to Investigate How Effective and Safe Solifenacin Liquid Suspension is in Treating Children/Adolescents Aged 5 to Less Than 18 Years With Symptoms of Overactive Bladder (OAB) Compared to a Non-active Drug (LION)

Study of Overactive Bladder in Women With Prolapse (SOAP)

An Exploratory Study to Investigate Bladder Contractions in the Storage Phase and Related Bladder Sensations in Healthy Females and Females With Overactive Bladder (OAB) Using High Resolution and Conventional Urodynamics

Interventions to Enhance Medication Persistence and Compliance in Patients With Overactive Bladder

Vaginal Electrical Stimulation Versus Neuromodulation

Single Dose Study to Measure Blood Levels and Safety of a Drug for Children With Overactive Bladder

Efficacy of Sanctura XR (Trospium Chloride) for Reducing Overactive Bladder Symptoms in Female Subjects Refractory to Detrol LA (Tolterodine Tartrate Extended Release) Daily

Urinary Nerve Growth Factor (NGF), Prostaglandin E2 (PGE2)and Adenosine Triphosphate (ATP): Potential Biomarkers in Overactive Bladder Patients

Therapy of the Overactive Bladder Syndrome (TOBS)

A Study of the Pharmacokinetics and Pharmacodynamics of MK4618 in Women With Overactive Bladder (MK-4618-004)

Trospium Chloride XR in Obese Female Patients With Overactive Bladder

Evaluation of Autonomic System Before and After Anticholinergic Treatment in Women With Overactive Bladder

A Phase 2 Study to Compare the Efficacy and Tolerability of Tarafenacin 0.2 mg and Tarafenacin 0.4 mg to Placebo Administered as Oral Daily Dose for Three Months in Patients Suffering From Overactive Bladder

Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder

Comparison of Motor and Sensory Response With Interstim Stimulation

Effects of Antimuscarinic Drugs on Overactive Bladder (OAB) Symptoms After Insertion of Ureteral Stents

A Prospective, Multi-center, Placebo-controlled, Randomized, Double-blind, Phase 2 Study to Compare the Efficacy and Tolerability of Tarafenacin 0.2 mg and Tarafenacin 0.4 mg to Placebo Administered as Oral Daily Dose for Three Months in Patients Suffering

Botox for the Treatment of Overactive Bladder Secondary to Benign Prostatic Obstruction

Post Marketing Surveillance Of Fesoterodine In Filipino Patients With Over Active Bladder

The Effect of Position on Urge Sensation in Volunteers and in Patients With Overactive Bladder Syndrome

Efficacy Study of Adalimumab to Treat Interstitial Cystitis

A Study to Evaluate the Efficacy, Safety and Tolerability of Mirabegron and Solifenacin Alone and in Combination for the Treatment of Overactive Bladder (Symphony)

A Study of the Efficacy and Safety of MK-4618 in Patients With Overactive Bladder (OAB) (MK-4618-008 AM1 EXT)

Combination Treatment With Doxazosin Plus TolterodineSR 2 mg Versus 4mg in Men With an Overactive Bladder (OAB) and Benign Prostatic Hyperplasia (BPH)

A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine

Combined Behavioral and Drug Treatment of Overactive Bladder in Men (COBALT)

Safety and Effectiveness of a Non-invasive Neuromodulation Device on Urgency Urinary Incontinence in Overactive Bladder (Beacon)

Effects and Safety of Liposome Encapsulated Botulinum Toxin A for Overactive Bladder Syndrome

Comparison of Solifenacin and Oxybutynin in the Treatment of Overactive Bladder

Comparative Urine Proteomic Studies of Overactive Bladder in Humans

A Clinical Study in Patients With Overactive Bladder With Leakage of Urine, to Find Out if the Medicine, Fesoterodine, Works in Those Patients Who Did Not Have Enough Response to the Medicine, Tolterodine.

Grouptraining for Overactive Bladder in Adults

Web-based Methodology Trial to Evaluate the Efficacy and Safety of Tolterodine ER in Subjects With Overactive Bladder (REMOTE)

Solifenacin Succinate (VESIcare) for the Treatment of Overactive Bladder in Parkinson's Disease (URGE-PD)

Comparison of Caffeine Reduction and Anticholinergic Medications for Treatment of Overactive Bladder

Overactive Bladder News

Transdermal Gel for Overactive Bladder Launched

Repeated Toxin Injections Safe and Effective for Refractory Overactive Bladder

Overactive Bladder Linked to Metabolic Syndrome in Women

Latest CME Article

Renal & Urology News includes a CME article in every print issue, which will also be available online.

View the latest installment:

Managing Bone Disease in  Kidney Transplant Recipients

Cartoons

Click here for our latest cartoons

On The Forefront

Sickle Cell Trait and Medullary Renal Carcinoma

A 55-year-old Caucasian woman initially presented to one of Cleveland Clinic's regional outpatient urology clinics with gross hematuria and an obstructing right ureteral stone.

Clinical Quiz

Small Renal Masses and Drug-Eluting Stents — How to Best Balance the Risks?

A 55-year-old male with significant history of coronary artery disease is found to have an intraparenchymal 2 cm left-enhancing small renal mass. Answer the quiz correctly and you'll have a chance to win an American Express gift card.